Delivery Order SPE2DB22D3301-SPE2DB23FZ4YT

Award Date 9/13/23
Potential Completion Date 9/14/23
Potential Value $247
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $46,350 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by September 28, 2023. No set aside designation or subcontractors were identified for this...
The Defense Logistics Agency awarded a $56,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by September 21, 2023. No subcontractors or set aside designations were identified....
The Defense Logistics Agency awarded a $770 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by September 8, 2023. No subcontractors or set aside designations were identified. The...
The Defense Logistics Agency awarded a $46,350 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the prescription drug Celecoxib. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania by the end date of August 28, 2023. No set aside designation or subcontractors were...
The Defense Logistics Agency awarded a $461 delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by August 9, 2023. The firm fixed price order was awarded non-competitively based on...
The Defense Logistics Agency awarded a $46,320 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 capsules of Celecoxib 100 mg. The order was placed under an existing Prime Vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by September 27, 2023 to support the Agency's medical readiness and logistics...
The Defense Logistics Agency awarded a $337,680 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an existing Prime Vendor contract vehicle to support the DLA's medical supply needs. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by mid-August 2023. No set aside designation or subcontractors were identified for this pharmaceutical...
The Defense Logistics Agency awarded a $56,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by June 22, 2023 to support the Defense Logistics Agency's medical supply needs. No...
The Defense Logistics Agency awarded a $291,780 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the prescription drug Celecoxib. As the prime contractor, Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by August 18, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues such requirements to support the medical readiness of U.S. armed forces worldwide.
The Defense Logistics Agency awarded a $56,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required by July 28, 2023. No subcontractors or set aside...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB23FZ4YT
    Delivery Order

The Defense Logistics Agency awarded a $247 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by September 14, 2023. No set aside designation or subcontractors were identified for this order to procure the non-steroidal anti-inflammatory drug Celecoxib, which supports the DLA's mission to provide medical supplies and equipment to military treatment facilities worldwide.

Generated 12/15/23, 10:51 PM